DAB2IP and cancer: Intriguingly, miR-889 is upregulated upon arsenite exposure via repression of its competitive circRNA-008913: the consequent DAB2IP downregulation and acquisition of cancer stem cell properties could partially explain the carcinogenic effect of arsenite [89].